Free Trial

Blair William & Co. IL Has $34.28 Million Position in DocuSign, Inc. (NASDAQ:DOCU)

DocuSign logo with Computer and Technology background
Remove Ads

Blair William & Co. IL decreased its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 4.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 381,082 shares of the company's stock after selling 15,961 shares during the period. Blair William & Co. IL owned about 0.19% of DocuSign worth $34,275,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kestra Investment Management LLC acquired a new stake in DocuSign during the 4th quarter valued at approximately $30,000. First Horizon Advisors Inc. lifted its position in shares of DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after purchasing an additional 201 shares during the last quarter. Modus Advisors LLC acquired a new position in DocuSign in the fourth quarter worth about $36,000. Itau Unibanco Holding S.A. bought a new stake in DocuSign in the third quarter valued at about $28,000. Finally, Avion Wealth raised its stake in DocuSign by 309.2% during the fourth quarter. Avion Wealth now owns 487 shares of the company's stock valued at $43,000 after buying an additional 368 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Stock Performance

Shares of NASDAQ:DOCU traded up $0.69 during midday trading on Tuesday, hitting $82.09. The company's stock had a trading volume of 723,785 shares, compared to its average volume of 2,681,526. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The stock has a market capitalization of $16.62 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 6.94 and a beta of 1.02. The stock's 50 day simple moving average is $87.01 and its 200 day simple moving average is $81.71.

Remove Ads

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same quarter in the prior year, the company earned $0.76 EPS. The firm's quarterly revenue was up 9.0% on a year-over-year basis. As a group, analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOCU. Wedbush restated a "neutral" rating and set a $100.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Bank of America reduced their price objective on DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and raised their target price for the company from $70.00 to $75.00 in a research note on Monday, March 10th. HSBC restated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Piper Sandler raised their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $95.83.

View Our Latest Research Report on DOCU

Insiders Place Their Bets

In other DocuSign news, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the completion of the sale, the insider now owns 43,781 shares in the company, valued at approximately $3,947,732.77. The trade was a 14.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now owns 156,050 shares of the company's stock, valued at $14,050,742. This trade represents a 20.40 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 97,851 shares of company stock valued at $8,579,369. 1.66% of the stock is currently owned by corporate insiders.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Articles

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads